Literature DB >> 11421623

Sickle cell disease: a chronic inflammatory condition.

J A Chies1, N B Nardi.   

Abstract

Homozygous sickle cell disease (SCD) has a wide spectrum of clinical manifestations which varies from an almost asymptomatic condition to severe illness, despite the fact that all subjects with this disease have the same base change in their DNA. The source of this variation is partly environmental, but a large part of this variability can derive from the presence of genetic modulators which are not fully understood. It was postulated that some degree of immunodeficiency should be associated with this condition, but no deficiency, directly related to a given component of the immune system, was observed that could explain the high levels of recurrent infections presented by sickle cell disease patients. Reviewing data from the literature we suggest that the influence of the immune system in the variation of clinical manifestations presented by SCD patients is not related with any immunodeficiency but is rather the result of a chronic inflammatory condition. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11421623     DOI: 10.1054/mehy.2000.1310

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  18 in total

1.  High levels of neopterin and interleukin-3 in sickle cell disease patients.

Authors:  L Rodrigues; F F Costa; S T O Saad; H Z W Grotto
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

Authors:  Christopher J Bean; Sheree L Boulet; Dorothy Ellingsen; Meredith E Pyle; Emily A Barron-Casella; James F Casella; Amanda B Payne; Jennifer Driggers; Heidi A Trau; Genyan Yang; Kimberly Jones; Solomon F Ofori-Acquah; W Craig Hooper; Michael R DeBaun
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

3.  Histopathology of experimentally induced asthma in a murine model of sickle cell disease.

Authors:  Sandhya D Nandedkar; Thomas R Feroah; William Hutchins; Dorothee Weihrauch; Kameswari S Konduri; Jingli Wang; Robert C Strunk; Michael R DeBaun; Cheryl A Hillery; Kirkwood A Pritchard
Journal:  Blood       Date:  2008-06-25       Impact factor: 22.113

4.  Hydroxyurea and Zileuton Differentially Modulate Cell Proliferation and Interleukin-2 Secretion by Murine Spleen Cells: Possible Implication on the Immune Function and Risk of Pain Crisis in Patients with Sickle Cell Disease.

Authors:  Solo Kuvibidila; Rajasekharan P Warrier; Johnson Haynes; Surendra B Baliga
Journal:  Ochsner J       Date:  2015

5.  Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Authors:  Bianca Maria Ricerca; Arturo Di Girolamo; Deborah Rund
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-28       Impact factor: 2.576

Review 6.  Heme on innate immunity and inflammation.

Authors:  Fabianno F Dutra; Marcelo T Bozza
Journal:  Front Pharmacol       Date:  2014-05-27       Impact factor: 5.810

7.  The CCR5Δ32 polymorphism in Brazilian patients with sickle cell disease.

Authors:  Mariana Pezzute Lopes; Magnun Nueldo Nunes Santos; Eliel Wagner Faber; Marcos André Cavalcanti Bezerra; Betânia Lucena Domingues Hatzlhofer; Dulcinéia Martins Albuquerque; Tânia Regina Zaccariotto; Daniela Maria Ribeiro; Aderson da Silva Araújo; Fernando Ferreira Costa; Maria de Fátima Sonati
Journal:  Dis Markers       Date:  2014-11-11       Impact factor: 3.434

8.  Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.

Authors:  Francesca Vinchi; Milene Costa da Silva; Giada Ingoglia; Sara Petrillo; Nathan Brinkman; Adrian Zuercher; Adelheid Cerwenka; Emanuela Tolosano; Martina U Muckenthaler
Journal:  Blood       Date:  2015-12-16       Impact factor: 22.113

9.  The association of CD81 polymorphisms with alloimmunization in sickle cell disease.

Authors:  Zohreh Tatari-Calderone; Ryad Tamouza; Gama P Le Bouder; Ramita Dewan; Naomi L C Luban; Jacqueline Lasserre; Jacqueline Maury; François Lionnet; Rajagopal Krishnamoorthy; Robert Girot; Stanislav Vukmanovic
Journal:  Clin Dev Immunol       Date:  2013-05-22

10.  [Hematological and nutritional profile of homozygous sickle cell SS aged 6 to 59 months in Lubumbashi, Democratic Republic of Congo].

Authors:  Mick Ya Pongombo Shongo; Olivier Mukuku; Augustin Mulangu Mutombo; Toni Kasole Lubala; Paul Makinko Ilunga; Winnie Umumbu Sombodi; Stanislas Okitotsho Wembonyama; OscarNumbi Luboya
Journal:  Pan Afr Med J       Date:  2015-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.